Ambrisentan in Single Ventricle

Clinical trial NCT02080637 · COMPLETED

Trial details

NCT number: NCT02080637
Sponsor: Kevin Hill
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypoplastic Left Heart Syndrome Hypoplastic Right-sided Heart Complex

Start date: 2015-07-01
Primary completion: 2017-07-20
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.